109121 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation; Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos; Techniques for producing new mammalian cloned embryos Swine embryos
METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#2PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES
#3METHODS FOR GENERATING GENETICALLY MODIFIED ANIMALS
#4NON-MEIOTIC ALLELE INTROGRESSION
#5DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES
#6Pathogen-resistant animals having modified CD163 genes
#7EFFICIENT NON-MEIOTIC ALLELE INTROGRESSION IN LIVESTOCK
#8ETV2 AND USES THEREOF
#9IMMUNOLOGICALLY COMPATIBLE CELLS, TISSUES, ORGANS, AND METHODS FOR TRANSPLANTATION FOR SILENCING, HUMANIZATION, AND PERSONALIZATION WITH MINIMIZED COLLATERAL GENOMIC DISRUPTIONS
#10METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#11DONOR PIGS FOR XENOTRANSPLANTATION
#12CELLS, TISSUES, ORGANS, AND/OR ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND/OR TOLERANCE
#13Methods for improving the health of porcine species by targeted inactivation of CD163
#14GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#15METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#16METHOD FOR DEVELOPING ORGAN THAT LACKS SPECIFIC FUNCTIONAL CELL
#17Pig with a genetically modified CD163 gene resistant to PRRSv
#18NON-MEIOTIC ALLELE INTROGRESSION
#19Pathogen-resistant animals having modified CD163 genes
#20Double knockout (GT/CMAH-KO) pigs, organs and tissues
#21CRISPR/Cas9 vector combination and application thereof in gene knockout
#22Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements
#23Method for preparing porcine fibroblasts with both CD163 gene and CD13 gene being knocked-out
#24Cold-resistant and lean-type transgenic pig and preparation method therefor
#25Method for developing organ that lacks specific functional cell
#26ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#27Non-meiotic allele introgression
#28Non-meiotic allele introgression
#29Non-meiotic allele introgression
#30PREPARATION METHOD FOR ANTI-PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME CLONED PIG
#31EFFICIENT NON-MEIOTIC ALLELE INTROGRESSION IN LIVESTOCK
#32Efficient non-meiotic allele introgression in livestock
#33Transgenic cloned piglet expressing human proinsulin and method of producing the same
#34Pathogen-resistant animals having modified CD163 genes
#35Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof
#36Multi-Transgenic Pig for Xenotransplantation
#37Double knockout (GT/CMAH-KO) pigs, organs and tissues
#38Disease model pig exhibiting stable phenotype, and production method thereof
#39Artificial oocyte activation
#40Efficient non-meiotic allele introgression
#41Genetically modified pig cells with an inactivated Etv2 gene
#42Pig model for diabetes
#43ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#44Pathogen-resistant animals having modified CD163 genes
#45Interleukin 2 receptor gamma gene targeting vector, production of immune cell-deficient transgenic cloned mini pig having vector introduced therein, preparation method therefor and use thereof
#46Recombination activating gene 2 gene targeting vector, production of SCID-like miniature pigs by TALEN-mediated gene targeting and use thereof
#47Double knockout (GT/CMAH-KO) pigs, organs and tissues
#48Artificial oocyte activation
#49Efficient non-meiotic allele introgression
#50CLONED NON-HUMAN ANIMALS FREE OF SELECTIVE MARKERS
#51Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
#52Pig whose genome comprises a heterologous site-specific recombination site and a transpohon tag
#53Transgenic pig as a model of Alzheimer's disease
#54Pig model for atherosclerosis
#55PIG MODEL FOR PSORIASIS
#56GFP-TRANSFECTED CLON PIG, GT KNOCK-OUT CLON PIG AND METHODS FOR PRODUCTIONS THEREOF
#57PIG MODEL FOR BREAST CANCER, MITOCHONDRIA RELATED PROTEIN FOLDING DISORDERS AND/OR EPIDERMOLYSIS BULLOSA SIMPLEX
#58Transgenic pig model for a hereditary neurodegenerative autosomal dominant disease
#59Method for the transfer of episomal vectors into animal cells
#60Cell nuclear transfer
#61Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
#62Method of producing cloned animals by demecolcine treatment
#63Porcine Nuclear Transfer
#64Cloning pigs using donor nuclei from differentiated cells
#65Method for the production of porcine nuclear transfer embryos
#66Method to enrich for α(1,3)-galactosyltransferase null pig cells
#67Methods of embryo transfer
#68Production of chimeric bovine or porcine animals using cultured inner cell mass
#69Method to decrease the rate of polyspermy in IVF
#70α(1,3)-galactosyltransferase knockout swine, tissues and organs
#71Cloning using donor nuclei from differentiated fetal and adult cells
#72Sex- specific selection of sperm from transgenic animals
#73"Gfp-transfected clon pig, gt knock-out clon pig and methods for productions thereof
#74Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease